Pharmala Biotech Holdings Inc.
MDMA
CNSX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 355.33% | 125.00% | 149.12% | 3,422.56% | -13.70% |
| Total Receivables | 94.22% | -70.95% | -57.81% | -61.48% | -34.14% |
| Inventory | 1.47% | 2.71% | 87.21% | 3,078.67% | 3,264.00% |
| Prepaid Expenses | -68.67% | 322.15% | 126.61% | -70.73% | -75.50% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 111.82% | 55.04% | 75.01% | 188.25% | 16.54% |
|
|
|||||
| Total Current Assets | 111.82% | 55.04% | 75.01% | 188.25% | 16.54% |
| Net Property, Plant & Equipment | -- | 600.00% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -5.04% | -6.24% | -2.72% | -4.98% | 3.12% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 29.69% | 15.91% | 25.41% | 48.06% | 6.69% |
|
|
|||||
| Total Accounts Payable | 80.47% | 4.93% | -15.44% | -48.74% | -51.72% |
| Total Accrued Expenses | -- | -- | -- | -87.74% | -67.59% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 27.51% | 8.11% | 24.60% | 3.33% | 50.72% |
| Total Other Current Liabilities | 27.51% | 8.11% | 24.60% | 3.33% | 50.72% |
| Total Current Liabilities | 42.13% | 3.05% | -1.65% | -32.89% | -20.02% |
|
|
|||||
| Total Current Liabilities | 42.13% | 3.05% | -1.65% | -32.89% | -20.02% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 42.13% | 3.05% | -1.65% | -32.89% | -20.02% |
|
|
|||||
| Common Stock & APIC | 25.17% | 25.27% | 27.51% | 34.75% | 20.27% |
| Retained Earnings | -39.14% | -41.34% | -41.91% | -36.02% | -28.55% |
| Treasury Stock & Other | 223.60% | 216.95% | 358.45% | -- | -- |
| Total Common Equity | 24.94% | 21.86% | 37.45% | 116.67% | 22.23% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 24.94% | 21.86% | 37.45% | 116.67% | 22.23% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 24.94% | 21.86% | 37.45% | 116.67% | 22.23% |
|
|
|||||